Related Experiment Video
Updated: May 5, 2026
06:19
Author Spotlight: A Novel Protocol for Intracameral Injections to Enhance Precision in Rodent Ophthalmology
Published on: May 31, 2024
1.9K
Ocular drug delivery for glaucoma management.
Nathan Gooch1, Sarah A Molokhia, Russell Condie
1Department of Bioengineering, University of Utah, Salt Lake City, UT, USA. barbara.wirostko@gmail.com.
Pharmaceutics
|December 5, 2013
Summary
New sustained-release treatments aim to improve glaucoma management by overcoming poor patient compliance with traditional eye drops. These innovative delivery systems show promise for better adherence and disease control.
Area of Science:
- Ophthalmology
- Drug Delivery Systems
- Glaucoma Research
Background:
- Current glaucoma treatments, primarily daily eye drops, suffer from low patient compliance and adherence.
- Complex regimens and poor patient understanding contribute to suboptimal treatment outcomes.
- Despite effective therapies, glaucoma progression persists, often linked to non-adherence.
Purpose of the Study:
- To review emerging sustained-release drug delivery systems for glaucoma.
- To address the challenges of patient compliance in current glaucoma management.
- To explore novel therapeutic strategies for improving intraocular pressure control.
Main Methods:
- Review of current clinical development for sustained-release glaucoma treatments.
- Analysis of various drug delivery systems including inserts and depots.
- Evaluation of potential to overcome patient compliance issues.
Main Results:
- Several sustained-release systems are in clinical development, including conjunctival, subconjunctival, and intravitreal inserts, punctal plugs, and drug depots.
- These novel systems offer potential for improved drug delivery and sustained therapeutic effects.
- While challenges exist for each system, they represent a promising advancement.
Conclusions:
- Sustained-release treatments offer a viable solution to improve patient compliance in glaucoma management.
- These innovative delivery methods have the potential to mitigate problems associated with poor adherence to daily eye drops.
- Further clinical development is expected to enhance glaucoma treatment efficacy and patient outcomes.
Related Concept Videos
01:23Ophthalmic Drug Delivery Systems
283
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
283
01:27Open Angle Glaucoma: Treatment
1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K
01:28Angle Closure Glaucoma: Treatment
1.6K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.6K
01:25Glaucoma: Overview
1.7K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.7K
01:22Drug Delivery: Miscellaneous Routes
1.1K
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
1.1K